APA (7th ed.) Citation

J, B., L, C., S, B., O, L., EM, M., W, R., . . . J, D. (2024). Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy. PloS one, 19(6), e0306329. https://doi.org/10.1371/journal.pone.0306329

Chicago Style (17th ed.) Citation

J, Bzdok, et al. "Quality Considerations and Major Pitfalls for High Throughput DNA-based Newborn Screening for Severe Combined Immunodeficiency and Spinal Muscular Atrophy." PloS One 19, no. 6 (2024): e0306329. https://doi.org/10.1371/journal.pone.0306329.

MLA (9th ed.) Citation

J, Bzdok, et al. "Quality Considerations and Major Pitfalls for High Throughput DNA-based Newborn Screening for Severe Combined Immunodeficiency and Spinal Muscular Atrophy." PloS One, vol. 19, no. 6, 2024, p. e0306329, https://doi.org/10.1371/journal.pone.0306329.